(Q34564930)

3 August 2017

1 reference

title

Potential role for rFVIIa in transfusion medicine (English)

1 reference

3 August 2017

Ulla Hedner

1

1 reference

3 August 2017

Elisabeth Erhardtsen

series ordinal

2

1 reference

3 August 2017

publication date

1 January 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

42

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

114-124

1 reference

Treatment of traumatic bleeding with recombinant factor VIIa.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Blood-borne tissue factor: another view of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Expression of tissue factor procoagulant activity: regulation by cytosolic calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Regulation of extravascular coagulation by microvascular permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Platelet activity of high-dose factor VIIa is independent of tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Clinical use of recombinant FVIIa (rFVIIa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Effect of Dextran on Factor VIII (Antihemophilic Factor) and Platelet Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Determinants of substrate specificity for factor XIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Use of recombinant factor VIIa in surgery in factor-VII-deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Management of anticoagulation before and after elective surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Deep venous thrombosis in hemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Unstable angina associated with factor VIII concentrate therapy for hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

Coronary artery disease in severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00017.X

10.1046/J.1537-2995.2002.00017.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference